Toho Holdings Co., Ltd.

Tokyo Stock Exchange 8129.T

Toho Holdings Co., Ltd. Shareholders' Equity for the year ending March 31, 2024: USD 1.65 B

Toho Holdings Co., Ltd. Shareholders' Equity is USD 1.65 B for the year ending March 31, 2024, a -9.87% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.
  • Toho Holdings Co., Ltd. Shareholders' Equity for the year ending March 31, 2023 was USD 1.83 B, a -7.71% change year over year.
  • Toho Holdings Co., Ltd. Shareholders' Equity for the year ending March 31, 2022 was USD 1.98 B, a -7.62% change year over year.
  • Toho Holdings Co., Ltd. Shareholders' Equity for the year ending March 31, 2021 was USD 2.14 B, a -0.20% change year over year.
  • Toho Holdings Co., Ltd. Shareholders' Equity for the year ending March 31, 2020 was USD 2.15 B, a 11.38% change year over year.
Key data
Date Shareholders' Equity Minority Interest Total Equity Total Stockholders Equity and Liabilities
Market news
Loading...
SV Wall Street
Tokyo Stock Exchange: 8129.T

Toho Holdings Co., Ltd.

CEO Mr. Hiromi Edahiro
IPO Date Dec. 11, 2002
Location Japan
Headquarters 5-2-1, Daizawa
Employees 7,572
Sector Healthcare
Industries
Description

Toho Holdings Co., Ltd. engages in the wholesale distribution of pharmaceutical products in Japan. It sells prescription pharmaceuticals, reagents, medical devices and materials, OTC drugs, health foods, preventive care, clinical care, community healthcare linkage, and home medical and nursing care, as well as provides support services, including the development and sale of customer support systems, assistance in the start-up of medical institutions and pharmacies, management consulting services, medical support, and personnel recruitment. The company also engages in dispensing pharmacy business; manufacture and sale of generic drugs; and site management organization business that assists various medical institutions with clinical trials under contract, as well as sells software to medical institutions. In addition, it provides various customer support systems, including ENIF, an information terminal for pharmaceutical ordering; ENI-Pharmacy, a support system for the separation of dispensing and prescribing functions; LXMATE HeLios a medical care appointment system; KAITOS, an online medical consultation and medication guidance system; ENIFwin, an inventory control system for large hospitals; ENIFvoice SP/ ENIFvoice SP + A/ ENIFvoice Core, a supporting system for electronic medication history recording with voice recognition; and ENIF Nurse, an operation support terminal for home-visit nurses; and logistics systems. The company was incorporated in 1948 and is headquartered in Tokyo, Japan.

Similar companies

7459.T

MediPal Holdings Corporation

USD 15.05

-0.63%

4553.T

Towa Pharmaceutical Co., Ltd.

USD 19.43

-1.89%

2784.T

Alfresa Holdings Corporation

USD 13.71

-0.73%

4540.T

Tsumura & Co.

USD 29.51

-0.48%

9987.T

Suzuken Co., Ltd.

USD 31.25

-0.69%

StockViz Staff

February 3, 2025

Any question? Send us an email